Skip to Main Content

Paper Details

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
J Am Coll Cardiol
36
2017
Children, HYDRA, HoFH, Homozygous Familial Hypercholesterolemia, Homozygous familial hypercholesterolemia, LDL, LDL receptor mutations, LDL-C, Patients, Rosuvastatin, Statin, atherosclerotic cardiovascular disease, children, cholesterol, ezetimibe, genetic disorder, low-density lipoprotein cholesterol, patients, rosuvastatin, statin
Author NameAffiliation
Daniel GaudetECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Universite de Montreal
Joel S RaichlenAstraZeneca Pharmaceuticals LP
John J P KasteleinAcademic Medical Center, University of Amsterdam
  • 1 - 3

Datasets

Release 1.2